Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

From plant physiology to human metabolic investigations

References

  1. 1.

    Robin ED (1979) Claude Bernard and his historical milieu. In: Robin ED (ed) Claude Bernard and the internal environment. Marcel Dekker, New York, Basel, pp 1–5

  2. 2.

    Helmer OM, Kirtley WR, Ridolfo AS (1957) Clinical and metabolic changes induced by glucagon in patients with rheumatoid arthritis. J Lab Clin Med 50: 824 (Abstract)

  3. 3.

    Lefèbvre P (1960) Influence du glucagon sur l'oedème local provoqué chez le rat par certaines substances phlogistiques. CR Soc Biol 155: 410–412

  4. 4.

    Lefèbvre P, Van Cauwenberge H (1962) Glucagon et réactions oedémateuses du rat. Arch Int Pharmacodyn Ther 138: 222–229

  5. 5.

    Lefèbvre P (1961) Influence de la surrénalectomie sur l'inhibition par le glucagon des réactions oedémateuses du rat. CR Soc Biol 155: 410–412

  6. 6.

    Lefèbvre P, Palem-Vliers M, Van Cauwenberge H (1961) Le glucagon stimule-t-il le cortex surrénalien du rat? CR Soc Biol 155: 1726–1728

  7. 7.

    Lefèbvre P, Dresse A (1961) Influence du glucagon sur le taux des catécholamines surrénaliennes chez le rat. CR Soc Biol 155: 412–414

  8. 8.

    Lefèbvre P (1962) Glucagon et inflammation expérimentale. Ann Endocrinol 23: 275–279

  9. 9.

    Scian LF, Westermann CD, Verdesca AS, Hilton JG (1960) Adreno-cortical and medullary effects of glucagon. Am J Physiol 199: 867–870

  10. 10.

    Lawrence AM (1965) A new provocative test for pheochromocytoma. Ann Intern Med 63: 905–906

  11. 11.

    Lefèbvre P, Cession-Fossion A, Luyckx AS (1966) Glucagon test for pheochromocytoma. Lancet 2: 1366

  12. 12.

    Lefèbvre P, Luyckx AS (1983) Glucagon and catecholamines. In: Lefèbvre P (ed) Glucagon. Handbook of experimental pharmacology 66, II, Springer, Berlin Heidelberg New York Tokyo, pp 536–543

  13. 13.

    Diamant D, Picazo J (1983) Spasmolytic action and clinical use of glucagon. In: Lefèbvre P (ed) Glucagon. Handbook of experimental pharmacology 66, II, Springer-Verlag, Berlin Heidelberg New York Tokyo, pp 611–643

  14. 14.

    Beggs I (1978) Pheochromocytoma diagnosed during a barium meal. Br J Radiol 51: 918

  15. 15.

    Geelhoed GW (1980) CAT scans and catecholamines. Surgery 87: 719–720

  16. 16.

    McLoughlin M, Langer B, Wilson DR (1981) Life-threatening reaction to glucagon in a patient with pheochromocytoma. Radiology 140: 841–842

  17. 17.

    Bernard C (1952) Introduction à la médecine expérimentale. Flammarion, Paris

  18. 18.

    Daubresse JC, Lerson G, Plomteux G, Rorive G, Luyckx AS, Lefèbvre PJ (1976) Lipids and lipoproteins in chronic uremia. A study of the influence of regular haemodialysis. Eur J Clin Invest 6: 159–166

  19. 19.

    Assan R (1972) In vivo metabolism of glucagon. In: Lefèbvre PJ, Unger RH (eds) Glucagon: molecular physiology, clinical and therapeutic implications. Pergamon, Oxford New York, pp 45–59

  20. 20.

    Bilbrey GL, Faloona GR, White MG, Knochel JP (1974) Hyperglucagonemia of renal failure. J Clin Invest 53: 841–847

  21. 21.

    Jaspan JB, Polonsky KS, Rubenstein AH (1983) Glucagon and renal insufficiency. In: Lefèbvre PJ (ed) Glucagon. Handbook of experimental pharmacology 66, II, Springer, Berlin Heidelberg New York Tokyo, pp 477–489

  22. 22.

    Lefèbvre PJ, Luyckx AS, Nizet AH (1974) Renal handling of endogenous glucagon in the dog: comparison with insulin. Metabolism 23: 753–761

  23. 23.

    Lefèbvre PJ, Luyckx AS, Nizet AH (1976) Independence of glucagon and insulin handling by the isolated perfused dog kidney. Diabetologia 12: 359–365

  24. 24.

    Lefèbvre PJ, Luyckx AS (1975) Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog. Metabolism 24: 1169–1176

  25. 25.

    Lefèbvre PJ, Luyckx AS (1976) Plasma glucagon after kidney exclusion: experiments in somatostatin-infused and in eviscerated dogs. Metabolism 25: 761–768

  26. 26.

    Kuku SF, Zeidler A, Emmanouel DS, Katz AI, Rubenstein AH, Levin NW, Tello A (1976) Heterogeneity of plasma glucagon patterns in patients with chronic renal failure and diabetes. J Clin Endocrinol Metab 42: 173–176

  27. 27.

    Kuku SF, Jaspan JB, Emmanouel DS, Zeidler A, Katz AI, Rubenstein AH (1976) Heterogeneity of plasma glucagon circulating components in normal subjects and patients with chronic renal failure. J Clin Invest 58: 742–750

  28. 28.

    Valverde I (1983) Heterogeneity of circulating glucagon and glucagon-like immunoreactivity. In: Lefèbvre PJ (ed) Glucagon. Handbook of experimental pharmacology 66, II, Springer, Berlin Heidelberg New York Tokyo, pp 223–244

  29. 29.

    Loly J, Luyckx AS, Lefèbvre PJ (1984) Renal control of cephalic and intestinal removal of glucagon in the anesthetized dog. Horm Metab Res 16: 308–310

  30. 30.

    Loly J, Luyckx AS, Lefèbvre PJ (1984) Renal control of the cephalic and intestinal uptake of glucagon in the anesthetized dog. Diabetes 33 (Suppl 1): 51A

  31. 31.

    Nier A (1947) A mass spectrometer for isotope and gas analysis. Rev Sci Inst 18: 398–411

  32. 32.

    McKinney C, McCrea J, Epstein S, Allen H, Urey H (1950) Improvements in mass spectrometry for the measurement of small differences in isotope abundance ratios. Rev Sci Inst 21: 724–730

  33. 33.

    Craig H (1957) Isotopic standards for carbon and oxygen and correction factors for mass spectrometric analysis of CO2. Geoch Cosmoch Acta 12: 133–149

  34. 34.

    Gibbs M, Latzko E (eds) (1979) Photosynthesis II. Photosynthetic carbon metabolism and related processes. Springer, Berlin Heidelberg New York Tokyo (Encyclopedia of plant physiology, Vol. 6.)

  35. 35.

    Troughton JH (1979) δ13C as an indicator of carboxylation reactions. In: Gibbs M, Latzko E (eds) Photosynthesis II. Photosynthetic carbon metabolism and related processes. Encylopedia of plant Physiology, Vol.6. Springer, Berlin Heidelberg New York, pp 140–149

  36. 36.

    Hatch M, Slack C (1966) Photosynthesis by sugar cane leaves: a new carboxylation reaction and the pathway of sugar formation. Biochem J 101: 103–111

  37. 37.

    Lacroix M, Mosora F, Pontus M, Lefèbvre P, Luyckx A, Lopez-Habib G (1973) Glucose naturally labeled with carbon-13: use for metabolic studies in man. Science 181: 445–446

  38. 38.

    Lacroix M, Mosora F (1975) Variations du rapport isotopique 13C/12C dans le métabolisme animal. In: Isotopes ratios as pollutant source and behaviour indicators. International Atomic Energy Agency, Vienna, pp 343–358

  39. 39.

    Mosora F, Lefèbvre P, Pirnay F, Lacroix M, Luyckx A, Duchesne J (1976) Quantitative evaluation of the oxidation of an exogenous glucose load using naturally labeled 13C-glucose. Metabolism 25: 1575–1582

  40. 40.

    Mosora F, Lacroix M, Luyckx AS, Pallikarakis N, Pirnay F, Krzentowski G, Lefèbvre P (1981) Glucose oxidation in relation to the size of the oral glucose loading dose. Metabolism 30: 1143–1149

  41. 41.

    Krebs HA, Hems R, Weidemann MJ, Speake RN (1966) The fate of isotopic carbon in kidney cortex synthesizing glucose from lactate. Biochem J 101: 242–249

  42. 42.

    Vranic M (1973) Tracer methodology and glucose turnover: an overview. Fed Proc 33: 1837–1840

  43. 43.

    Allsop JR, Wolfe RR, Burke JF (1978) Tracer priming the bicarbonate pool. J Appl Physiol: Respir Environ Exercise Physiol 45: 137–139

  44. 44.

    Krzentowski G, Jandrain B, Pirnay F, Mosora F, Lacroix M, Luyckx A, Lefèbvre P. J. (1984) Availability of glucose given orally during exercise. J Appl Physiol: Respir Environ Exercise Physiol 56: 315–320

  45. 45.

    Costill DL, Benett A, Branam G, Eddy D (1973) Glucose ingestion at rest and during prolonged exercise. J Appl Physiol 34: 764–769

  46. 46.

    Van Handel PJ, Finck WJ, Branam G, Costill DL (1980) Fate of 14C-glucose ingested during prolonged exercise. Int J Sports Med 2: 127–131

  47. 47.

    Pirnay F, Lacroix M, Mosora F, Luyckx A, Lefèbvre P (1977) Glucose oxidation during exercise evaluated with naturally labeled 13C-glucose. J Appl Physiol 43: 258–261

  48. 48.

    Pirnay F, Krzentowski G, Crielaard JM, Pallikarakis N, Lacroix M, Mosora F, Luyckx A, Lefèbvre P (1981) Oxidation of orally administered “naturally-labeled 13C-glucose” during prolonged muscular exercise. In: Poortmans J, Niset G (eds) Biochemistry of exercise IV B. University Park Press, Baltimore, pp 196–207

  49. 49.

    Pirnay F, Crielaard JM, Pallikarakis N, Lacroix M, Mosora F, Krzentowski G, Luyckx A, Lefèbvre PJ (1982) Fate of exogenous glucose during exercise of different intensities in humans. J Appl Physiol: Respir Environ Exercise Physiol 53: 1620–1624

  50. 50.

    Krzentowski G, Pirnay F, Pallikarakis N, Luyckx AS, Lacroix M, Mosora F, Lefèbvre PJ (1981) Glucose utilization during exercise in normal and diabetic subjects. The role of insulin. Diabetes 30: 983–989

  51. 51.

    Apfelbaum E (ed) (1946) Maladie de famine. Recherches cliniques sur la famine exécutées dans le ghetto de Varsovie en 1942. American Joint Distribution Committee, Warsaw

  52. 52.

    Winick M (ed) Hunger disease. Studies by the Jewish Physicians in the Warsaw ghetto. J Wiley and Sons, New York, 1979

  53. 53.

    Björkman O, Berry J (1973) High-efficiency photosynthesis. Sci Am 229: 80–93

  54. 54.

    Lyon TDB, Baxter MS (1978) Stable carbon isotopes in human tissues. Nature 273: 750–751

Download references

Author information

Additional information

1984 Claude Bernard Lecture of the European Association for the Study of Diabetes delivered in London on 15 September 1984

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lefèbvre, P.J. From plant physiology to human metabolic investigations. Diabetologia 28, 255–263 (1985). https://doi.org/10.1007/BF00271681

Download citation

Keywords

  • Public Health
  • Internal Medicine
  • Plant Physiology
  • Human Physiology
  • Metabolic Disease